These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 34580763)

  • 41. Prevalence and Spectrum of DICER1 Mutations in Adult-onset Thyroid Nodules with Indeterminate Cytology.
    Chong AS; Nikiforov YE; Condello V; Wald AI; Nikiforova MN; Foulkes WD; Rivera B
    J Clin Endocrinol Metab; 2021 Mar; 106(4):968-977. PubMed ID: 33460435
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Dicer expression and microRNA dysregulation associate with aggressive features in thyroid cancer.
    Erler P; Keutgen XM; Crowley MJ; Zetoune T; Kundel A; Kleiman D; Beninato T; Scognamiglio T; Elemento O; Zarnegar R; Fahey TJ
    Surgery; 2014 Dec; 156(6):1342-50; discussion 1350. PubMed ID: 25456905
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Thyroblastoma: A DICER1-associated embryonal neoplasm and fine needle aspiration diagnostic criteria.
    Jitpasutham T; Faquin WC; Torous VF; Nosé V
    Diagn Cytopathol; 2023 May; 51(5):E142-E148. PubMed ID: 36688366
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Thyroid Nodules and Follicular Cell-Derived Thyroid Carcinomas in Children.
    Slack JC; Hollowell M; Barletta JA
    Endocr Pathol; 2023 Jun; 34(2):165-175. PubMed ID: 37160531
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [DICER1 syndrome: clinical variety endocrine manifestations and features of diagnostics].
    Novokreshennih EE; Kolodkina AA; Bezlepkina OB
    Probl Endokrinol (Mosk); 2023 Oct; 70(2):78-85. PubMed ID: 38796764
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Identification of somatic and germ-line DICER1 mutations in pleuropulmonary blastoma, cystic nephroma and rhabdomyosarcoma tumors within a DICER1 syndrome pedigree.
    Fernández-Martínez L; Villegas JA; Santamaría Í; Pitiot AS; Alvarado MG; Fernández S; Torres H; Paredes Á; Blay P; Balbín M
    BMC Cancer; 2017 Feb; 17(1):146. PubMed ID: 28222777
    [TBL] [Abstract][Full Text] [Related]  

  • 47. DICER1 mutations in familial multinodular goiter with and without ovarian Sertoli-Leydig cell tumors.
    Rio Frio T; Bahubeshi A; Kanellopoulou C; Hamel N; Niedziela M; Sabbaghian N; Pouchet C; Gilbert L; O'Brien PK; Serfas K; Broderick P; Houlston RS; Lesueur F; Bonora E; Muljo S; Schimke RN; Bouron-Dal Soglio D; Arseneau J; Schultz KA; Priest JR; Nguyen VH; Harach HR; Livingston DM; Foulkes WD; Tischkowitz M
    JAMA; 2011 Jan; 305(1):68-77. PubMed ID: 21205968
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Anaplastic sarcomas of the kidney are characterized by DICER1 mutations.
    Wu MK; Vujanic GM; Fahiminiya S; Watanabe N; Thorner PS; O'Sullivan MJ; Fabian MR; Foulkes WD
    Mod Pathol; 2018 Jan; 31(1):169-178. PubMed ID: 28862265
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Hereditary predispositions to follicular thyroid tumors].
    Decaussin-Petrucci M
    Ann Pathol; 2020 Apr; 40(2):142-147. PubMed ID: 32192806
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Ovarian embryonal rhabdomyosarcoma is a rare manifestation of the DICER1 syndrome.
    de Kock L; Druker H; Weber E; Hamel N; Traubici J; Malkin D; Arseneau J; Stewart CJ; Bouron-Dal Soglio D; Priest JR; Foulkes WD
    Hum Pathol; 2015 Jun; 46(6):917-22. PubMed ID: 25836323
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Metachronous anaplastic sarcoma of the kidney and thyroid follicular carcinoma as manifestations of DICER1 abnormalities.
    Yoshida M; Hamanoue S; Seki M; Tanaka M; Yoshida K; Goto H; Ogawa S; Takita J; Tanaka Y
    Hum Pathol; 2017 Mar; 61():205-209. PubMed ID: 27697588
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A family with Sertoli-Leydig cell tumour, multinodular goiter, and
    Haley M; Bindal P; McAuliffe A; Vredenburgh J
    Curr Oncol; 2019 Jun; 26(3):183-185. PubMed ID: 31285663
    [TBL] [Abstract][Full Text] [Related]  

  • 53. GABPA inhibits invasion/metastasis in papillary thyroid carcinoma by regulating DICER1 expression.
    Yuan X; Mu N; Wang N; Strååt K; Sofiadis A; Guo Y; Stenman A; Li K; Cheng G; Zhang L; Kong F; Ekblad L; Wennerberg J; Nilsson IL; Juhlin CC; Larsson C; Xu D
    Oncogene; 2019 Feb; 38(7):965-979. PubMed ID: 30181547
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Multinodular goitre is a gateway for molecular testing of DICER1 syndrome.
    Oliver-Petit I; Bertozzi AI; Grunenwald S; Gambart M; Pigeon-Kerchiche P; Sadoul JL; Caron PJ; Savagner F
    Clin Endocrinol (Oxf); 2019 Nov; 91(5):669-675. PubMed ID: 31408196
    [TBL] [Abstract][Full Text] [Related]  

  • 55. DICER1 and FOXL2 Mutation Status Correlates With Clinicopathologic Features in Ovarian Sertoli-Leydig Cell Tumors.
    Karnezis AN; Wang Y; Keul J; Tessier-Cloutier B; Magrill J; Kommoss S; Senz J; Yang W; Proctor L; Schmidt D; Clement PB; Gilks CB; Huntsman DG; Kommoss F
    Am J Surg Pathol; 2019 May; 43(5):628-638. PubMed ID: 30986800
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Recurrent DICER1 hotspot mutations in endometrial tumours and their impact on microRNA biogenesis.
    Chen J; Wang Y; McMonechy MK; Anglesio MS; Yang W; Senz J; Maines-Bandiera S; Rosner J; Trigo-Gonzalez G; Grace Cheng SW; Kim J; Matzuk MM; Morin GB; Huntsman DG
    J Pathol; 2015 Oct; 237(2):215-25. PubMed ID: 26033159
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Germ-line and somatic DICER1 mutations in pineoblastoma.
    de Kock L; Sabbaghian N; Druker H; Weber E; Hamel N; Miller S; Choong CS; Gottardo NG; Kees UR; Rednam SP; van Hest LP; Jongmans MC; Jhangiani S; Lupski JR; Zacharin M; Bouron-Dal Soglio D; Huang A; Priest JR; Perry A; Mueller S; Albrecht S; Malkin D; Grundy RG; Foulkes WD
    Acta Neuropathol; 2014 Oct; 128(4):583-95. PubMed ID: 25022261
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Rare Germline
    Martínez de LaPiscina I; Hernández-Ramírez LC; Portillo N; Gómez-Gila AL; Urrutia I; Martínez-Salazar R; García-Castaño A; Aguayo A; Rica I; Gaztambide S; Faucz FR; Keil MF; Lodish MB; Quezado M; Pankratz N; Chittiboina P; Lane J; Kay DM; Mills JL; Castaño L; Stratakis CA
    Front Endocrinol (Lausanne); 2020; 11():433. PubMed ID: 32714280
    [No Abstract]   [Full Text] [Related]  

  • 59. Targeted next-generation sequencing panel (ThyroSeq) for detection of mutations in thyroid cancer.
    Nikiforova MN; Wald AI; Roy S; Durso MB; Nikiforov YE
    J Clin Endocrinol Metab; 2013 Nov; 98(11):E1852-60. PubMed ID: 23979959
    [TBL] [Abstract][Full Text] [Related]  

  • 60. An update on the central nervous system manifestations of DICER1 syndrome.
    de Kock L; Priest JR; Foulkes WD; Alexandrescu S
    Acta Neuropathol; 2020 Apr; 139(4):689-701. PubMed ID: 30953130
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.